Alnylam Pharmaceuticals | Ativos



Assets Alterar Data
Acadia Pharmaceuticals USD 1.13B 55.39M 2025-03
Agios Pharmaceuticals USD 1.56B 107.68M 2025-03
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Amgen USD 89.37B 2.47B 2025-03
Arrowhead Research USD 1.57B 559.8M 2025-03
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Incyte USD 5.75B 305.04M 2025-03
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
Moderna USD 12.7B 1.44B 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12
PTC Therapeutics USD 2.66B 950.36M 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Sanofi 132.8B 3.04B 2024-12
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
Takeda JPY 14.25T 858.5B 2025-03
Tectonic Therapeutic USD 152.9M 15.81M 2024-12
Ultragenyx Pharmaceutical USD 1.31B 191.53M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12
Xencor USD 904.69M 47.26M 2025-03



Alnylam Pharmaceuticals Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.